Cellular Health Screening Market Regional Analysis:
North American Market Insights
The North America region is set to hold 33% share of the global cellular health screening market by 2034. The market domination can be attributed to increasing awareness about personalized medicines, growing government initiatives supporting preventive healthcare, and growing adoption of new technologies. Besides this robust expansion of healthcare infrastructure in the North American region will boost the market growth. In June 2021, Grail launched a unique blood test capable of detecting the presence of multiple cancers using the Galleri diagnostic method. This test is intended to screen people at high risk of cancer, such as adults over 50 years old.
Asia Pacific Market Insights
The cellular health screening market in the Asia Pacific is estimated to hold a substantial growth during the forecast timeframe. The increase in the number of people, which is contributing to a large patient pool and creating an infrastructure for health care due to increased economic activity, will fuel the market expansion. Additionally, the market revenie is impelled by improved adoption of tests and awareness by adults about their health. Regional growth is also supported by higher research on telomere senescence, as well as public policies aimed at preventing diseases.
